1. Ishikawa T, Shimizu D, Kito A, Ota I, Sasaki T, Tanabe M, Yamada A, Arioka H, Shimizu S, Wakasugi J, Mori R, Chishima T, Ichikawa Y, Endo I (2012) Breast cancer manifested by hematologic disorders. J Thorac Dis 4:650–654
2. Wheeler SB, Reeder-Hayes K, Meyer AM (2012) A balancing act for breast cancer? Everolimus for hormone receptor positive patients. Transl Cancer Res 1:109–112
3. Wang YX, Wang DW, Zhu XM, Zhao F, Leung KC (2012) Carbon coated superparamagnetic iron oxide nanoparticles for sentinel lymph nodes mapping. Quant Imaging Med Surg 2:53–56
4. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M (2011) Global burden of metabolic risk factors of chronic diseases collaborating group (blood glucose) national, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40
5. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764